Cybrexa Therapeutics Employee Directory
Biotechnology ResearchConnecticut, United States11-50 Employees
Cybrexa Therapeutics is a clinical-stage biotechnology company focused on oncology, based in New Haven, Connecticut. It develops peptide-drug conjugates that do not rely on tumor-specific antigens to deliver potent anticancer agents directly to cancer cells. The platform targets acidic surfaces on tumor cells to enable tumor-selective delivery, with a focus on cancers such as ovarian, breast, and non-small cell lung cancer. Its lead candidate, CBX-12, has progressed into early clinical evaluations in patients with metastatic cancer. The company operates in the biotechnology research sector as a privately held entity guided by a leadership team experienced in building life science companies and drug development in oncology. Recent activity includes presenting preclinical data on tumor-targeting peptide-drug conjugates at major oncology forums in 2025, reflecting ongoing development of targeted oncology therapies.
1-888-653-2347 
support@leadiq.com 
